SecBot SecBot
SECBOTREPLAY Home › Report › ABBV

ABBV · AbbVie Inc

AbbVie Inc. · DEFA14A filed Mar 23, 2026 at 17:01 ET

At the news

NEUTRALIMPACT 3/10

DEFA14A filed Mar 23, 2026 at 17:01 ET

AbbVie Inc. is holding its 2026 Annual Meeting for shareholders. The proxy statement includes proposals to elect four Class II directors, ratify the independent auditor, approve executive compensation (Say on Pay), amend the certificate of incorporation to eliminate supermajority voting, and vote on a shareholder proposal to adopt an independent chair. This is routine corporate governance material.

  • Annual meeting scheduled for May 8, 2026.
  • Four Class II directors are up for election: Jennifer L. Davis, Melody B. Meyer, Robert A. Michael, and Frederick H. Waddell.
  • Proposal to ratify Ernst & Young LLP as the independent auditor for 2026.
  • Say on Pay advisory vote on executive compensation.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access